ObsEva Banner Image


  • Ticker OBSV
    Exchange NASDAQ More
  • Industry Medical Laboratories & Research More
  • Sector Healthcare More
ObsEva Logo Image
  • 11-50 Employees
  • Based in Geneva, Switzerland
ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosisMore, uterine fibroids, preterm labor and improving ART outcomes.
4.8 / 5.0 (104)

ObsEva reports have an aggregate usefulness score of 4.8 based on 104 reviews.


Most Recent Annual Report

MOST RECENT 2022 Annual Report

ObsEva does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

ObsEva Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!